Zobrazeno 1 - 4
of 4
pro vyhledávání: '"N. V. Chertov"'
Publikováno v:
Медицинский вестник Юга России, Vol 14, Iss 2, Pp 97-105 (2023)
The problem of chronic traumatic encephalopathy is extremely relevant from both medical and sports points of view. Unfortunately, in the domestic literature to date, this issue is not discussed enough. The consequences of repetitive mild traumatic br
Externí odkaz:
https://doaj.org/article/c9c52845e4184f46bb328db356317adb
Autor:
Ya. V. Sboeva, Yu. S. Vasil’eva, N. V. Chertov, N. A. Pystogova, S. V. Boronnikova, R. N. Kalendar, N. A. Martynenko
Publikováno v:
Сибирский лесной журнал, Vol 7, Iss 4, Pp 35-44 (2020)
The use of DNA-fingerprinting of forest-forming woody plants is considered the most promising tool for genetic control of wood’s geographic origin, the formation of a reliable management system for harvesting and turnover of lumber. The purpose of
Externí odkaz:
https://doaj.org/article/dacf2f0daf6d4b358966192111f754e4
Autor:
A. S. Binyatova, E. D. Mytsa, N. V. Chertova, R. A. Volkova, K. A. Sarkisyan, T. N. Ilyasova, T. N. Yunasova, A. A. Movsesyants, V. A. Merkulov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 18, Iss 4, Pp 249-256 (2018)
Currently, the identity of measles, mumps and rubella virus vaccines is determined during certification testing by a labour-consuming, lengthy and costly neutralisation test using cell cultures. The identity of the virus contained in such vaccines is
Externí odkaz:
https://doaj.org/article/38a7b8cefc584c1187eeb5e2ee035318
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 18, Iss 2, Pp 75-80 (2018)
Biotechnological products manufactured by recombinant DNA technology are widely used nowadays. According to the national and international requirements the amount of residual host cell DNA in such products should not exceed 10 ng per dose. However, f
Externí odkaz:
https://doaj.org/article/182449c03c9e418baa8d80c501e5d76c